Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Rapamycin increases pCREB, Bcl-2, and VEGF-A through ERK under normoxia.

Liu Y, Zheng Q, Wu H, Guo X, Li J, Hao S.

Acta Biochim Biophys Sin (Shanghai). 2013 Apr;45(4):259-67. doi: 10.1093/abbs/gmt002. Epub 2013 Feb 11.

PMID:
23403511
[PubMed - indexed for MEDLINE]
2.

Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mechanism.

Cammarota M, Bevilaqua LR, Dunkley PR, Rostas JA.

J Neurochem. 2001 Dec;79(6):1122-8.

PMID:
11752053
[PubMed - indexed for MEDLINE]
3.

Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.

Namkoong S, Kim CK, Cho YL, Kim JH, Lee H, Ha KS, Choe J, Kim PH, Won MH, Kwon YG, Shim EB, Kim YM.

Cell Signal. 2009 Jun;21(6):906-15.

PMID:
19385062
[PubMed - indexed for MEDLINE]
4.

Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways.

Wang K, Jiang YZ, Chen DB, Zheng J.

Placenta. 2009 Dec;30(12):1045-51. doi: 10.1016/j.placenta.2009.10.007. Epub 2009 Nov 5.

PMID:
19892399
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin.

Frost P, Shi Y, Hoang B, Gera J, Lichtenstein A.

Mol Cancer Ther. 2009 Jan;8(1):83-93. doi: 10.1158/1535-7163.MCT-08-0254.

PMID:
19139116
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.

Bidwell P, Joh K, Leaver HA, Rizzo MT.

Prostaglandins Other Lipid Mediat. 2010 Feb;91(1-2):18-29. doi: 10.1016/j.prostaglandins.2009.12.002. Epub 2009 Dec 14.

PMID:
20015475
[PubMed - indexed for MEDLINE]
8.
9.

PDGF-induced vascular smooth muscle cell proliferation is associated with dysregulation of insulin receptor substrates.

Zhao Y, Biswas SK, McNulty PH, Kozak M, Jun JY, Segar L.

Am J Physiol Cell Physiol. 2011 Jun;300(6):C1375-85. doi: 10.1152/ajpcell.00670.2008. Epub 2011 Feb 16.

PMID:
21325637
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.

Marzec M, Kasprzycka M, Liu X, El-Salem M, Halasa K, Raghunath PN, Bucki R, Wlodarski P, Wasik MA.

Oncogene. 2007 Aug 16;26(38):5606-14. Epub 2007 Mar 12.

PMID:
17353907
[PubMed - indexed for MEDLINE]
12.

Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells.

Ikari A, Sanada A, Sawada H, Okude C, Tonegawa C, Sugatani J.

Biochim Biophys Acta. 2011 Jun;1808(6):1502-8. doi: 10.1016/j.bbamem.2010.11.006. Epub 2010 Nov 10.

PMID:
21073857
[PubMed - indexed for MEDLINE]
Free Article
13.

Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt.

Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz JB.

J Neurosci. 2002 Aug 1;22(15):6401-7.

PMID:
12151519
[PubMed - indexed for MEDLINE]
Free Article
14.

Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors.

Kurmasheva RT, Harwood FC, Houghton PJ.

Mol Cancer Ther. 2007 May;6(5):1620-8. Epub 2007 May 4.

PMID:
17483438
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity.

Trisciuoglio D, Iervolino A, Candiloro A, Fibbi G, Fanciulli M, Zangemeister-Wittke U, Zupi G, Del Bufalo D.

J Biol Chem. 2004 Feb 20;279(8):6737-45. Epub 2003 Dec 1.

PMID:
14660675
[PubMed - indexed for MEDLINE]
Free Article
18.

Inhibition of the mammalian target of rapamycin promotes cyclic AMP-induced differentiation of NG108-15 cells.

Chin TY, Kao CH, Wang HY, Huang WP, Ma KH, Chueh SH.

Autophagy. 2010 Nov;6(8):1139-56. Epub 2010 Nov 16.

PMID:
20935515
[PubMed - indexed for MEDLINE]
Free Article
19.

Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.

Manov I, Pollak Y, Broneshter R, Iancu TC.

FEBS J. 2011 Sep;278(18):3494-507. doi: 10.1111/j.1742-4658.2011.08271.x.

PMID:
21790999
[PubMed - indexed for MEDLINE]
20.

Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.

Kobayashi S, Kishimoto T, Kamata S, Otsuka M, Miyazaki M, Ishikura H.

Cancer Sci. 2007 May;98(5):726-33.

PMID:
17425689
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk